logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10004802 B1

PDFFull Text
Expired
Date of Patent:
Jun. 26, 2018

Filed:

Apr. 27, 2012

Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cells

Applicants:

Takashi Kei Kishimoto, Lexington, MA (US);

Christopher Fraser, Arlington, MA (US);

Roberto A. Maldonado, Jamaica Plain, MA (US);

Inventors:

Takashi Kei Kishimoto, Lexington, MA (US);

Christopher Fraser, Arlington, MA (US);

Roberto A. Maldonado, Jamaica Plain, MA (US);

Assignee:

Selecta Biosciences, Inc., Watertown, MA (US);

Attorney:

Wolf, Greenfield & Sacks, P.C.

Primary Examiner:

Phuong Huynh

Int. Cl.
CPC ...
A61K 47/68 (2017.01); A61K 39/00 (2006.01); C07K 16/18 (2006.01); A61K 9/51 (2006.01); A61K 9/58 (2006.01); A61K 47/00 (2006.01); A61K 9/14 (2006.01); A61K 39/385 (2006.01); A61K 39/35 (2006.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01); B82Y 5/00 (2011.01); A61K 39/36 (2006.01); A61K 9/127 (2006.01); A61K 38/38 (2006.01); A61K 31/192 (2006.01); A61K 38/13 (2006.01); A61K 38/18 (2006.01); A61K 47/50 (2017.01); A61K 47/52 (2017.01); A61K 47/54 (2017.01); A61K 47/59 (2017.01); A61K 47/64 (2017.01); A61K 47/69 (2017.01); B82Y 40/00 (2011.01);
U.S. Cl.
CPC ...
A61K 39/385 (2013.01); A61K 9/127 (2013.01); A61K 9/14 (2013.01); A61K 9/51 (2013.01); A61K 9/5115 (2013.01); A61K 9/5146 (2013.01); A61K 9/5153 (2013.01); A61K 31/192 (2013.01); A61K 38/13 (2013.01); A61K 38/1816 (2013.01); A61K 38/38 (2013.01); A61K 39/00 (2013.01); A61K 39/001 (2013.01); A61K 39/0008 (2013.01); A61K 39/35 (2013.01); A61K 39/36 (2013.01); A61K 47/50 (2017.08); A61K 47/52 (2017.08); A61K 47/544 (2017.08); A61K 47/593 (2017.08); A61K 47/643 (2017.08); A61K 47/69 (2017.08); A61K 47/6923 (2017.08); A61K 47/6929 (2017.08); A61K 47/6937 (2017.08); B82Y 5/00 (2013.01); G01N 33/505 (2013.01); G01N 33/56972 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/577 (2013.01); B82Y 40/00 (2013.01); G01N 2333/7051 (2013.01); G01N 2333/70514 (2013.01); G01N 2333/70517 (2013.01);
Abstract

Disclosed are synthetic nanocarrier methods, and related compositions, comprising administering MHC Class I-restricted and/or MHC Class II-restricted epitopes of an antigen and immunosuppressants in order to generate tolerogenic immune responses against the antigen, such as the generation of antigen-specific CD8+ regulatory T cells.

Find Patent Forward Citations

Kishimoto, Takashi. (2018). Tolerogenic synthetic nanocarriers for generating cd8+ regulatory t cells (U.S. Patent No. 10004802). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10004802

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…